SEREVENTDISKUS (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the SEREVENT drug offered from GlaxoSmithKline LLC. This Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | salmeterol xinafoate |
| SUBSTANCE NAME: | SALMETEROL XINAFOATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| ROUTE: | ORAL; RESPIRATORY (INHALATION) |
| DOSAGE FORM: | POWDER, METERED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1997-12-01 |
| END MARKETING DATE: | 0000-00-00 |
SEREVENT DISKUS HUMAN PRESCRIPTION DRUG Details:
| Item Description | SEREVENT DISKUS from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(ug/1) |
| START MARKETING DATE: | 1997-12-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0173-0520_cf2a6bca-db87-42e2-b279-018a75e231a1 |
| PRODUCT NDC: | 0173-0520 |
| APPLICATION NUMBER: | NDA020692 |
Other SALMETEROL XINAFOATE Pharmaceutical Manufacturers / Labelers:
